Historical review from 2026-11-11. Current price and availability are unconfirmed; check the original marketplace.

← Back to 2026-11-11 Deals
#20

Stacker: Peptide Tracker

Health & FitnessListed on TrustMRR· Nov 2
$15.0K
Asking Price
$437/mo
Monthly Revenue
$428/mo
Monthly Profit
2.9x
Profit Multiple
N/A
Business Age
✨

Why We Picked This

Stacker is a verified iPhone app in the health & fitness niche that tracks peptide protocols, logging doses, reminders, and progress. The financials are remarkably clean: ~$428/mo profit on ~$437/mo revenue yields a 98% margin, which is exceptionally high and consistent with a low-overhead app-store product. At a $15,000 asking price the annual profit multiple comes to approximately 2.92x — a reasonable figure for a small mobile app. The business age is not disclosed and the revenue base is modest, so a buyer should validate the consistency of that revenue over time and understand the acquisition channel before committing.

👍

Strengths

  • ✓Platform-verified financials with a 98% profit margin — exceptional for a mobile app business
  • ✓Reasonable 2.92x annual profit multiple at $15K ask, within the standard range for small app acquisitions
  • ✓Clear niche focus (peptide tracking) with an underserved, enthusiastic user base in the growing biohacking and longevity community
  • ✓Very low overhead implied by near-100% margins — likely minimal hosting or third-party API costs
  • ✓App-store distribution provides inherent discoverability without heavy paid marketing
🔎

Details to confirm

  • •Business age is not disclosed — request monthly revenue history (ideally 12+ months) to confirm revenue stability and trend direction
  • •App Store review count, active subscriber count, and churn rate are not included in the listing; a buyer should request these to assess retention durability
  • •Acquisition channel breakdown (organic search, App Store SEO, social, word-of-mouth) would help a buyer understand what drives new installs and whether growth is sustainable
  • •Confirm whether $436/mo revenue is recurring subscription, one-time purchases, or a mix, as this significantly affects valuation confidence

Additional details to confirm

Evidence 60/100
Business age unavailableUnusually high reported profit margin

Buy vs Build: BUY

52
AI-native cash cost
$2.0K–$6.0K
Estimated time
6 weeks
Asking price
$15.0K

The core software — a mobile peptide tracker with dose logging, reminders, and progress views — is straightforwardly reproducible by a solo founder using an AI coding assistant, SwiftUI or React Native, and a managed backend like Supabase. Out-of-pocket build cost would likely fall between $2,000–$6,000 including tools, App Store fees, and modest design assets. However, the case for buying rests on acquiring the existing verified revenue stream (~$428/mo profit), established App Store presence, and any organic ratings/reviews that lower user acquisition friction — assets that take time and iteration to earn, not just dollars. The verdict tips narrowly to buy because the 2.92x multiple is fair for verified recurring income, but the missing retention data and undisclosed business age meaningfully limit confidence. A buyer who can quickly confirm 6–12 months of stable revenue history and healthy churn will have strong justification for proceeding.

Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.

📊

Financial Snapshot

$5K
Annual Revenue
$5K
Annual Profit
$0.4K
Monthly Revenue
35 mo
Est. Payback
Profit Margin98%
📋

Business Overview

Helps users build personalized peptide stacks, log doses, get reminders, and track protocol progress and results in one iPhone app.

📌

Quick Facts

🏢
Type
Health & Fitness
🏪
Source
TrustMRR
📌
Listed
Nov 2, 2026

Deal Score

62
Interesting
Evidence confidence60/100
2.9x
Good Multiple
Asking$15.0K
MRR$437/mo
Profit$428/mo
Profit Multiple2.9x
View on TrustMRR →

Opens the original listing on TrustMRR

Share this review

Know a buyer or the founder? Send them the full analysis.

Share on X
New listings by email

See tomorrow’s businesses for sale.

Get new listings with asking prices, monthly profit, deal scores, and key risks.

The best reviewed deals, concise and evidence-first. Unsubscribe anytime.

Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.